Mutual of America Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $282K | Sell |
|
|||||
|
2025
Q1 | $289K | Sell |
|
|||||
|
2024
Q4 | $307K | Buy |
|
|||||
|
2024
Q3 | $275K | Sell |
|
|||||
|
2024
Q2 | $234K | Sell |
|
|||||
|
2024
Q1 | $206K | Sell |
|
|||||
|
2023
Q4 | $205K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $231K | Sell |
|
|||||
|
2023
Q1 | $243K | Sell |
|
|||||
|
2022
Q4 | $225K | Sell |
|
|||||
|
2022
Q3 | $275K | Buy |
|
|||||
|
2022
Q2 | $253K | Buy |
|
|||||
|
2022
Q1 | $271K | Buy |
|
|||||
|
2021
Q4 | $353K | Buy |
|
|||||
|
2021
Q3 | $310K | Sell |
|
|||||
|
2021
Q2 | $1.92M | Sell |
|
|||||
|
2021
Q1 | $2.26M | Sell |
|
|||||
|
2020
Q4 | $1.51M | Buy |
|
|||||
|
2020
Q3 | $1.44M | Buy |
|
|||||
|
2020
Q2 | $1.67M | Sell |
|
|||||
|
2020
Q1 | $1.11M | Sell |
|
|||||
|
2019
Q4 | $1.68M | Sell |
|
|||||
|
2019
Q3 | $1.69M | Sell |
|
|||||
|
2019
Q2 | $1.98M | Sell |
|
|||||
|
2019
Q1 | $2.26M | Sell |
|
|||||
|
2018
Q4 | $2.55M | Buy |
|
|||||
|
2018
Q3 | $110K | Buy |
|
|||||
|
2018
Q2 | $16K | Buy |
|
|||||
|
2014
Q3 | – | Sell |
|
|||||
|
2014
Q2 | $25K | Buy |
|